A study to compare different doses of fenebrutinib with a “placebo” – in patients with an autoimmune disease called “chronic spontaneous urticaria”

Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)

Infectious Diseases

Results
Download
Print

Study results

LPS GS39684 Final Results June 2020 English (PDF, 0.1 MB)

LPS GS39684 Final Results June 2020 Canada French (PDF, 0.1 MB)

LPS GS39684 Final Results June 2020 German (PDF, 0.1 MB)

LPS GS39684 Final Results June 2020 US Spanish (PDF, 0.1 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A study to compare different doses of fenebrutinib with a “placebo” – in patients with an autoimmune disease called “chronic spontaneous urticaria”

Study results

LPS GS39684 Final Results June 2020 English (PDF, 0.1 MB)

LPS GS39684 Final Results June 2020 Canada French (PDF, 0.1 MB)

LPS GS39684 Final Results June 2020 German (PDF, 0.1 MB)

LPS GS39684 Final Results June 2020 US Spanish (PDF, 0.1 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A study to compare different doses of fenebrutinib with a “placebo” – in patients with an autoimmune disease called “chronic spontaneous urticaria”

For the latest version of this information please go to www.forpatients.roche.com